Log In
Print this Print this


Also known as: 249320

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionAntibody against myelin associated glycoprotein (MAG)
Molecular Target Myelin associated glycoprotein (MAG)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationStroke
Indication DetailsTreat stroke
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today